ARCHIVES

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

This article is from The Cancer Letter archive.

Vol. 25 No. 45 | November 26, 1999

Download PDF Visit The Full Archive

Related Articles

UC Davis Study Finds Patients Need Practical Information

June 28, 2002

In Brief: Reducing Doses Cuts Cure Rate Every Time, DeVita Says; Hyperthermia Use In Cancer Being Assessed

April 6, 1984

ASCO Hit On Two Sides; AACR Split Criticized

June 26, 1992

Cancer Policy: President’s Cancer Panel Issues Statement On National Cancer Program

September 17, 1999

NCAB Members Skeptical On NCI Reorganization; King Has “Alterative;” Terry T Head Centers

January 27, 1978

FDA Grants Orphan Designation To Photofrin for Mesothelioma

December 30, 2011